| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Feb 2025 | 3 Feb 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 11th February 2025 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter Ended on 31st December 2024. 2. Any other matter with the permission of the Chair. We hereby inform you that the Board of Directors of the Company in its meeting held today on February 11, 2025, have, inter alia, considered and approved the following matters: 1. The Board considered the proposal to expand/modernize the business of the company. 2. The Board considered the revised proposal for fund raising by the company for above expansion / modernization through the proposed rights issue from a sum not exceeding Rs. 700 lakhs to Rs. 750 lakhs to the eligible equity shareholders of the Company in accordance with the applicable laws subject to regulatory approval, if any as intimated earlier. 3. The Board considered the unaudited financial result with limited review for the nine months period ended 31st December 2024 and authorized its Managing Director to taking required action for its publication in accordance with requirements of SEBILODR, 2015. The Board meeting commenced at 7.00 pm and concluded at 11.00 pm (As Per BSE Announcement Dated on: 11.02.2025) | ||
| Board Meeting | 23 Jan 2025 | 17 Jan 2025 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve Please refer the letter dated as on 17/01/2025 for the upcoming meeting of the board to consider important matters of the company. Please refer board outcome in the letter attached (As per BSE Announcement Dated on 23/01/2025) Revision of Outcome of the board meeting held on 23rd January 2025. Due to Inadvertence/Typographical error proposed right issue approved by the board was mentioned as Rs 500 lakhs in the announcement made previously but it should be Rs 700 lakhs Please refer revised outcome for your reference. (As Per BSE Announcement Dated on 24/01/2025) | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half year Ended on 30th September 2024. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 7th November 2024, we wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 14th November 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikhroli - West, Mumbai - 400079 at 5.00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2024 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting of Board of Directors commenced at 5:00 p.m. and concluded at 11.00 pm (As Per Bse Announcement Dated on 14.11.2024) | ||
| Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th June 2024. 2. Any other matter with the permission of the Chair. 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for thequarter ended on 30th June 2024 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Took on record the resignation letter dated August 14th ,2024 received from M/s PD Dalal & Co. (FRN: 102047W) from the post of Statutory Auditor of the Company w.e.f. August 14th, 2024, due to other commitments and that there is no other material reason for the resignation. 3. Recommendation for appointment of M/s. Maheshwari & Co., Chartered Accountants (Firm Registration No.: 105834W), Mumbai as the Statutory Auditors the meeting of Board of Directors commenced at 12.00 p.m. and concluded at 3.00p.m (As per BSE Announcement dated on 14/08/2024) | ||
| Board Meeting | 28 May 2024 | 17 May 2024 |
| Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2024. 2. Any other matter with the permission of the Chair. We wish to inform you that the meeting of the Board of Directors of the Company held Today i.e. Tuesday, May 28, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 2 p.m., and has transacted the following businesses: 1. Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2024 and Auditors Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2024. - The meeting of Board of Directors commenced at 2.00 pm and concluded at 5.30 pm. Read less.. (As Per BSE Announcement Dated on 28.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
